Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Prednisone
Related studies linked through entity extraction aliases.
Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Prednisone for Decompensated Congestive Heart Failure
- Status
- SUSPENDED
- Phase
- PHASE2/PHASE3
SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Cell Biology of Steroid Resistant Asthma
- Status
- COMPLETED
- Phase
- NA
Ph II CHOP+Velcade in Mediastinal LBCL
- Status
- TERMINATED
- Phase
- PHASE2
Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide for Patients With Myelofibrosis (MF)
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease
- Status
- COMPLETED
- Phase
- NA
Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.
- Status
- UNKNOWN
- Phase
- PHASE2
Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE3
Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)
- Status
- COMPLETED
- Phase
- PHASE2
PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC
- Status
- TERMINATED
- Phase
- PHASE2
Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients
- Status
- TERMINATED
- Phase
- PHASE3
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)
- Status
- COMPLETED
- Phase
- PHASE2